Veraxa Biotech AG - Post de-SPAC
VRXA · VRXAW · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Gruninger Marc: Form 4
Insider disclosure · Filed · Report period 27 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0002079109 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- VRXA, VRXAW on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Talacker 35, Zurich, 8001
- Incorporated in
- Switzerland
- Fiscal year end
- 31 December
- Former names on EDGAR
- Veraxa Biotech Holding AG (to 13 Aug 2026)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields